Adicon Holdings Limited (HKG:9860)

Market Cap	3.14B -28.1%
Revenue (ttm)	3.06B -2.4%
Net Income	26.76M
EPS	0.04
Shares Out	715.47M
PE Ratio	125.46
Forward PE	35.16
Dividend	n/a
Ex-Dividend Date	n/a

Volume	48,000
Open	4.400
Previous Close	4.335
Day's Range	4.325 - 4.400
52-Week Range	3.160 - 7.630
Beta	0.09
Analysts	Buy
Price Target	6.17 (+40.32%)
Est. Earnings	Nov 25, 2026

About Adicon Holdings

Adicon Holdings Limited, an investment holding company, provides medical testing services in the People’s Republic of China. The company offers testing services primarily to hospitals and health check centers through an integrated network of self-operated laboratories; and research and clinical trial services. It is also involved in the trading of medical testing equipment. The company was founded in 2004 and is headquartered in Hangzhou, the People’s Republic of China.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2004
• Employees: 5,024
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 9860

Financial Performance

In 2025, Adicon Holdings's revenue was 2.64 billion, a decrease of -9.46% compared to the previous year's 2.91 billion. Earnings were 18.44 million, a decrease of -60.77%.

Financial numbers in CNY

Analyst Summary

According to 4 analysts, the average rating for 9860 stock is "Buy." The 12-month stock price target is $6.17, which is an increase of 40.32% from the latest price.

Price Target

$6.17

(40.32% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 11, 2026

Data Sources Report a data error